| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +100.00% | +30.54% | +2.34% | +28.20% | +28.20% | — |
| 14d | 2 | +50.00% | +58.59% | +0.15% | +58.44% | +58.44% | — |
| 30d | 2 | +50.00% | +52.17% | +8.67% | +43.51% | +43.51% | — |
| 60d | 2 | +100.00% | +127.68% | +8.69% | +118.99% | +118.99% | — |
| 90d | 2 | +100.00% | +96.88% | +3.23% | +93.64% | +93.64% | — |
| 180d | 2 | +100.00% | +192.45% | +7.65% | +184.80% | +184.80% | — |
| 1y | 2 | +100.00% | +319.82% | +20.50% | +299.33% | +299.33% | — |
| 2y | 2 | +50.00% | +3.46% | +57.02% | -53.56% | -53.56% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. | PURCHASEGRANT Stock grant | 40,925 | — | — | 40,925 | Mar 18, 2026 | Mar 20, 2026 ↗ | View → |
| RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. | PURCHASEGRANT Stock grant | 194,250 | — | — | 194,250 | Feb 13, 2025 | Feb 18, 2025 ↗ | View → |
| RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. | PURCHASEGRANT Stock grant | 96,519 | — | — | 96,519 | Sep 15, 2024 | Sep 17, 2024 ↗ | View → |
| RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. | PURCHASEGRANT Stock grant | 170,000 | — | — | 170,000 | Apr 25, 2023 | Apr 27, 2023 ↗ | View → |
| RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. | PURCHASE Chief Financial Officer | 50,000 | $1.66 | $83.0K | 100,000 | Sep 30, 2022 | Oct 3, 2022 ↗ | View → |
| RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. | PURCHASE Chief Financial Officer | 50,000 | $1.21 | $60.7K | 50,000 | Jun 30, 2022 | Jun 30, 2022 ↗ | View → |
| RVPH REVIVA PHARMACEUTICALS HOLDINGS, INC. | PURCHASEGRANT Stock grant | 50,000 | — | — | 50,000 | Apr 14, 2021 | Apr 15, 2021 ↗ | View → |